SCHEMBL11929010

SCHEMBL11929010

CNS(=O)(=O)c1cc(C(=O)NN2C(C)CCCC2C)cc(Cl)c1Cl

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 2/20 0.60
▸ KDM4E B2RXH2 2/20 0.60
▸ HTT P42858 2/20 0.60
▸ GLA P06280 1/20 0.60
▸ MAPT P10636 1/20 0.60
▸ HSD17B10 Q99714 1/20 0.60
▸ PTPN1 P18031 1/20 0.47
▸ HSD11B1 P28845 1/20 0.39
▸ SMN1; SMN2 Q16637 2/20 0.38
▸ CA12 O43570 1/20 0.38
▸ ALDH1A1 P00352 1/20 0.38
▸ CA1 P00915 1/20 0.38
▸ CA2 P00918 1/20 0.38
▸ CA3 P07451 1/20 0.38
▸ GAA P10253 1/20 0.38
▸ CA4 P22748 1/20 0.38
▸ CA6 P23280 1/20 0.38
▸ CA5A P35218 1/20 0.38
▸ PTGS2 P35354 1/20 0.38
▸ CA7 P43166 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11925216 0.89 LMNA (0.58) LMNAKDM4EHTTGLAMAPT
Clopamide SCHEMBL1650071 0.75 KDM4E (1.00) LMNAKDM4EHTTGLAMAPT
SCHEMBL27462399 0.75 LMNA (0.83) LMNAKDM4EHTTGLAMAPT
Clopamide SCHEMBL124598 0.75 KDM4E (1.00) LMNAKDM4EHTTGLAMAPT
SCHEMBL8971767 0.66 LMNA (0.65) LMNAKDM4EHTTGLAMAPT
SCHEMBL31151392 0.66 LMNA (0.65) LMNAKDM4EHTTGLAMAPT
SCHEMBL13823308 0.64 ALDH1A1 (0.81) LMNAKDM4EHTTGLAMAPT
SCHEMBL14394547 0.63 LMNA (0.47) LMNAKDM4EHTTGLAMAPT
SCHEMBL11929104 0.63 LMNA (0.47) LMNAKDM4EHTTGLAMAPT
SCHEMBL11929253 0.62 CA1 (0.68) LMNACA12CA1CA2CA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180194732-A1 MULTI-API LOADING PRODRUGS JPMORGAN CHASE BANK, N.A. AS ADMINISTRATIVE AGENT 2018-07-12 — — US disclosed
US-20160024011-A1 Multi-API Loading Prodrugs ALKERMES PHARMA IRELAND LTD (IE) 2016-01-28 — — US disclosed
US-20120202823-A1 Multi-API Loading Prodrugs ALKERMES, INC. 2012-08-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160024011-A1 Multi-API Loading Prodrugs AADAC, PAICS, ABCG2 LMNA 2855/4885KDM4E 423/4885HTT 3691/4885
US-20120202823-A1 Multi-API Loading Prodrugs AADAC, PAICS, ABCG2 LMNA 2855/4885KDM4E 423/4885HTT 3691/4885
US-20180194732-A1 MULTI-API LOADING PRODRUGS AADAC, PAICS, ABCG2 LMNA 2855/4885KDM4E 423/4885HTT 3691/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback